PCS is a steroid supplier and a contract manufacturer. As such, it specializes on a contract basis in steroid APIs and intermediates, custom fermentation and aseptic/sterile dosage form manufacturing.
Early work at PCS, a commercial group within Pfizer Global Manufacturing, involved the development of large-scale, cost-effective, synthetic routes for corticosteroids and hormonal steroids.
Nice rated PCS's CP at 76% for Q3; the same as Hospira and B-I before it. PCS pulls in with a 56% CA for Q3, compared with Hospira's 38%.